Latest posts
-
Alzheimer’s Drugs Can Slow Decline, Not Reverse It
Lecanemab changed the conversation about Alzheimer’s treatment by targeting amyloid in the brain. Its trial results point to slower decline for some people—not restored memory or a cure.